Comparative proteomics of Hirschsprung's disease

Area of Science:

• Gastroenterology
• Developmental Biology
• Proteomics

Background:

• Hirschsprung's disease (HSCR) is a congenital disorder affecting the enteric nervous system, leading to bowel motility disturbances.
• Current treatments for HSCR often result in long-term functional deficits, highlighting a need for improved therapeutic strategies.
• The precise pathophysiological mechanisms underlying HSCR and its postoperative complications remain unclear.

Purpose of the Study:

• To investigate protein expression alterations in Hirschsprung's disease patients using proteomics.
• To identify potential biomarkers and elucidate the molecular mechanisms of disturbed bowel function in HSCR.
• To compare protein expression in aganglionic and ganglionic segments of HSCR patients with healthy controls.

Main Methods:

• Proteomic analysis using 2-DE (two-dimensional electrophoresis) was performed on tissue samples from HSCR patients.
• Comparative analysis of protein expression profiles between aganglionic and ganglionic segments of HSCR patients.
• Expression levels of altered proteins were also compared between HSCR patients and normal children.

Main Results:

• A total of 16 proteins exhibited differential expression in the aganglionic segment of HSCR patients.
• These identified proteins encompass diverse functions, including cytoskeleton components, regulatory proteins, and enzymes.
• Altered protein expression was also observed in the ganglionic segment of HSCR patients compared to controls.

Conclusions:

• The ganglionic segment in HSCR patients is not entirely normal, suggesting a broader impact of the disease.
• These proteomic findings provide crucial insights into the pathomechanisms of HSCR-associated bowel dysfunction.
• Understanding these molecular alterations can contribute to the development of more effective therapies for Hirschsprung's disease.